Economy & Markets
GLP-1 injections recalled nationwide over sterility concerns
The FDA classified Apothecary Pharma's nationwide recall of 23 injectable drug vials as Class II. The company previously received a warning over sterile drug production.
Read more at FOX BIZ ›
Read the full story at
FOX BIZ
The Gadsden Report aggregates and summarises headlines. The reporting above belongs to FOX BIZ, and the link opens their page. This page exists so readers can find, share, and discuss the story here.